The genetic background of antidepressant response represents a unique opportunity to identify biological markers of treatment outcome. Encouraging results alternating with inconsistent findings made antidepressant pharmacogenetics a stimulating but often discouraging field that requires careful discussion about cumulative evidence and methodological issues.
Understanding the pharmacogenetics of selective serotonin reuptake inhibitors / Fabbri, C.; Minarini, A.; Niitsu, T.; Serretti, A.. - In: EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. - ISSN 1742-5255. - STAMPA. - 10:8(2014), pp. 1093-1118. [10.1517/17425255.2014.928693]
Understanding the pharmacogenetics of selective serotonin reuptake inhibitors
FABBRI, CHIARA;NIITSU, TOMIHISA;SERRETTI, ALESSANDRO
2014
Abstract
The genetic background of antidepressant response represents a unique opportunity to identify biological markers of treatment outcome. Encouraging results alternating with inconsistent findings made antidepressant pharmacogenetics a stimulating but often discouraging field that requires careful discussion about cumulative evidence and methodological issues.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
